Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fox Chase Cancer Center
British Columbia Cancer Agency
University of Maryland, Baltimore
Stanford University
Virginia Commonwealth University
University of Erlangen-Nürnberg Medical School
University of Southern California
The University of Texas Health Science Center, Houston